Boris Vaisman
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 1%
- Cholesterol and Lipid Metabolism
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 47
- Cholesterol and Lipid Metabolism 37
- Lipoproteins and Cardiovascular Health 13
-
- Peroxisome Proliferator-Activated Receptors 11
- Co-authors
- Alan T. Remaley (30 shared papers)Silvia Santamarina-Fojo (21 shared papers)Marcelo Amar (22 shared papers)Robert D. Shamburek (12 shared papers)Robert F. Hoyt (10 shared papers)H Bryan Brewer (9 shared papers)Abraham M. Konijn (11 shared papers)Beverly Paigen (8 shared papers)
- Journals
- Journal of Lipid Research (9 papers)Journal of Biological Chemistry (8 papers)Blood (7 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)Atherosclerosis (4 papers)
- Partner nations
- United StatesIsraelJapan
In The Last Decade
Boris Vaisman
89 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 123
- Endocrinology, Diabetes and Metabolism 989
- Surgery 2.1k
- Cancer Research 707
- Biochemistry 310
- Oncology 659
Countries citing papers authored by Boris Vaisman
This map shows the geographic impact of Boris Vaisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Vaisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Vaisman more than expected).
Fields of papers citing papers by Boris Vaisman
This network shows the impact of papers produced by Boris Vaisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Vaisman. The network helps show where Boris Vaisman may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Vaisman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 231 | |
| 2 | 1996 | 195 | |
| 3 | 2001 | 190 | |
| 4 | 1999 | 178 | |
| 5 | 2001 | 178 | |
| 6 | 1997 | 172 | |
| 7 | 2009 | 140 | |
| 8 | 1999 | 132 | |
| 9 | 1995 | 103 | |
| 10 | 2001 | 100 | |
| 11 | 1997 | 93 | |
| 12 | 1996 | 92 | |
| 13 | 2013 | 83 | |
| 14 | 2011 | 80 | |
| 15 | 2010 | 80 | |
| 16 | 2016 | 69 | |
| 17 | 2006 | 69 | |
| 18 | 2004 | 66 | |
| 19 | 1997 | 66 | |
| 20 | 2004 | 62 |
About Boris Vaisman
Boris Vaisman is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology and Cancer Research, having authored 89 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (37 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers), Lipoproteins and Cardiovascular Health (13 papers), Drug Transport and Resistance Mechanisms (13 papers), Peroxisome Proliferator-Activated Receptors (11 papers), Cancer, Lipids, and Metabolism (9 papers), Lipid metabolism and biosynthesis (9 papers) and Hemoglobinopathies and Related Disorders (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (989 citations), Surgery (2.1k citations), Cancer Research (707 citations), Biochemistry (310 citations) and Oncology (659 citations). Boris Vaisman has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Alan T. Remaley, Silvia Santamarina-Fojo, Marcelo Amar, Robert D. Shamburek, Robert F. Hoyt, H Bryan Brewer, Abraham M. Konijn, Beverly Paigen, H. Bryan Brewer and Charles Joyce. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Blood, Journal of Pharmacology and Experimental Therapeutics and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.